It is the hypothesis that the use of NHEJ inhibitors alone can induce cell death via synthetic lethality, as DDR is altered under hypoxia, and these changes are exacerbated in some ovarian cancers with mutated MMR pathways. Here, MRC1 is linked to ovarian cancer.